Ian Wyatt Recommends the Following Stock: Biolase Technology.Business Editors CHICAGO--(BUSINESS WIRE)--Feb. 6, 2003 Ian Wyatt has done it again. He's found another high growth company in a resilient sector that's poised for profits, but remains underrepresented un·der·rep·re·sent·ed adj. Insufficiently or inadequately represented: the underrepresented minority groups, ignored by the government. . Get a stock recommendation for a dental technologies leader that will leave you smiling. Learn about Biolase Technology, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BLTI BLTI Blonder Tongue Laboratories, Inc. ). Click here for the full story exclusively on Zacks.com: http://featuredexpert2bw.zacks.com/ Here are the highlights from the Featured Expert column: Biolase Technology, Inc. (NASDAQ:BLTI) designs, develops, manufactures, and markets dental, cosmetic, and surgical products. The Waterlase, Biolase's core product, uses HydroKinetic hydrokinetic /hy·dro·ki·net·ic/ (hi?dro-ki-net´ik) relating to movement of water or other fluid, as in a whirlpool bath. hy·dro·ki·net·ic or hy·dro·ki·net·i·cal adj. technology to perform a number of dental procedures including cavity prevention, caries caries or tooth decay Localized disease that causes decay and cavities in teeth. It begins at the tooth's surface and may penetrate the dentin and the pulp cavity. removal, tooth etching etching, the art of engraving with acid on metal; also the print taken from the metal plate so engraved. In hard-ground etching the plate, usually of copper or zinc, is given a thin coating or ground of acid-resistant resin. , and a number of soft tissue or gum procedures. There remains a huge potential for expansion in the U.S. as consumer-driven growth encourages dentists to purchase new laser technologies. The company has been in high growth mode, growing revenue from $9.7 million in 2000 to $17.9 million in 2001. And analysts are looking for Looking for In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with. 2002 revenue to come in at $28 million, representing 56% growth. Biolase recently stated that it expects fourth quarter earnings per share to come in at the high end of its previous guidance of 2 cents to 5 cents a share. The company earned a penny a share in the first quarter, three cents in the second quarter, and four cents in the third. If the company hits the high end of guidance, as announced, 2002 EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format. would come in at 13 cents. Wyatt expects the company to announce a strong fourth quarter on February 12, and hopes management will provide strong guidance for the year ahead at that time. Get additional information on Biolase Technology while keeping tabs on other high growth companies, along with Ian Wyatt' s complete commentary, by clicking: http://featuredexpert3bw.zacks.com/ About Zacks Featured Experts To be a successful investor you need professional advice. Experts who know what they're talking about and can help you achieve your financial goals in good markets...and especially in bad ones will help you improve your portfolio. That is why Zacks Investment Research Zacks Investment Research A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms. has assembled the best investment experts in the business to offer their powerful advisory newsletters to you on all the major investment topics: Stocks, Mutual Funds, Bonds, Options, Futures etc. Recommendations from Featured Experts Highlighted in FREE Investment Newsletter The best way to tap into the powerful advice from these experts is through our free weekly e-mail newsletter, "Profit from the Pros". Each week we highlight several Featured Experts in this free e-mail See Internet e-mail service. newsletter. Get your free subscription to "Profit from the Pros" at: http://www.freeprofit1bw.zacks.com About Zacks Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1981 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind our work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. Our goal is to unlock their profitable insights for our customers. And there is no better way to enjoy this investment success, than with a FREE subscription to "Profit from the Pros" weekly e-mail newsletter. For your free newsletter, visit http://www.freeprofitbw.zacks.com Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation solicitation In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual to buy or sell any security. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion